Clinical examination of nitroglycerin spray (EGIS) in angina pectoris patients.
On the basis of our examinations it may be stated that the new product of EGIS Pharmaceuticals Nitromint aerosol seems to be effective and well tolerable in the course of clinical examinations. The drug action develops significantly more rapidly as compared to Nitromint tablet. Significant difference was not found when comparing the duration of action of the two products. The adverse effects are the same as the undesired effects of other short-acting nitrate preparations. Mostly local unwanted effects were observed. It can be recommended in all forms of angina pectoris for controlling pain syndrome and in effort angina for prophylactic purposes. In acute left heart failure it may be used in urgent cases. Because of its effectiveness and easy applicability the patients prefer Nitromint aerosol to Nitromint tablet.